You are here

Award Data

For best search results, use the search terms first and then apply the filters

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Marburg Virus Prophylactic Medical Countermeasure

    SBC: MAPP BIOPHARMACEUTICAL, INC.            Topic: CBD18A002

    There are currently no vaccines or therapeutics available for Marburg Virus Disease (MVD). Given the specter of weaponization and the terrible morbidity and high mortality rate of MVD, this represents a critical threat to the operational readiness of the Warfighter. While traditional vaccines have contributed greatly to public health, they have some limitations especially in the context of operati ...

    STTR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense
  2. The Development and Systematic Evaluation of an AI-Assisted Just-in-Time-Adaptive-Intervention for Improving Child Mental Health

    SBC: Colliga Apps Corp.            Topic: 104

    PROJECT SUMMARY/ABSTRACT Early childhood mental health problems constitute a significant public health concern with wide-ranging impacts on functioning both concurrently and later in life. Although childhood mental health is influenced by a variety of factors, the quality of relationships with caregivers plays a critical role. Critical, coercive, and conflictual parent- child interactions have bee ...

    STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  3. FH-Fc as a Pre-Exposure Prophylactic for Tickborne Disease

    SBC: Planet Biotechnology Incorporated            Topic: NIAID

    Lyme disease (LD) is the most prevalent vector-borne disease in the United States, with up to 300,000 cases a year. LD is caused by several species of the spirochete bacteria Borrelia burgdorferi sensu lato (the Lyme borreliae), which are transmitted by ticks from animal (bird, rodent) reservoirs to human hosts. While a short course of antibiotics is usually effective in eliminating the bacteria a ...

    STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  4. Vaccination against Zika virus infection using mosquito NeSt1 protein

    SBC: L2 DIAGNOSTICS LLC            Topic: NIAID

    Arthropod-borne viruses (arboviruses) present a substantial threat to human and animal health worldwide. They are transmitted by hematophagous arthropods, in which mosquitoes are one of the main transmitters. The mosquito specie, Aedes aegypti, is the primary mosquito vector of several widely spread arboviruses as zika, dengue or West Nile viruses. Mosquitoes transmit these pathogens by inoculatin ...

    STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  5. VICENT- Vibration Imaging for the Characterization of Extended, Non-cooperative Targets

    SBC: EXCITING TECHNOLOGY LLC            Topic: AF19AT006

    Exciting Technology, LLC (ET) and University of Dayton Research Institute (UDRI) along with their Transition partner Lockheed Martin Coherent Technologies (LMCT) plan to extend the Phase I phenomenology and wave optics simulations, and build a vibration imaging LiDAR for target phenomenology characterizations in controlled environments.  In addition, the team provides an optional path to accelera ...

    STTR Phase II 2020 Department of DefenseAir Force
  6. Tilt-Nose Control System Development for High-Speed Stratospheric Interceptors

    SBC: ATA ENGINEERING, INC.            Topic: MDA18T002

    Recent advances in the hypersonic system capabilities of adversary nations threaten the battlespace supremacy of US forces. Missile defense systems capable of extended high-g maneuvering at stratospheric altitudes and hypersonic Mach numbers will provide the MDA with additional flexibility in defending the US against emerging hypersonic threats. A key enabling technology for the deployment of such ...

    STTR Phase II 2020 Department of DefenseMissile Defense Agency
  7. Intelligent Robot Path Planning System for Grinding of Aircraft Propeller Blades

    SBC: Traclabs Inc.            Topic: AF19AT004

    This is an augmentation of a robotic installation Robin AFB GXMG has been using for over a decade. Each C-130 prop that needs grinding for remanufacture will no longer be treated exactly the same (since they are not). 3D sensing will adapt a grinding process to the exact blade geometry. Furthermore, if a prop need to be processed further (to remove pitting or scratches), the system will target onl ...

    STTR Phase II 2020 Department of DefenseAir Force
  8. Toolset For Prediction of Carbon-Carbon Aeroshell Properties Based On Constituent Materials And Manufacturing Process Parameters

    SBC: ATA ENGINEERING, INC.            Topic: AF19AT021

    Carbon-carbon (C-C) composites are used in the fabrication of aeroshells and thermal protection systems (TPS) in hypersonic and atmospheric reentry applications because they maintain their strength at elevated temperatures and have desirable thermal conductivity properties. Although these materials have been used in mission-critical components for decades, the effects of variations in processing m ...

    STTR Phase II 2020 Department of DefenseAir Force
  9. Marburg Virus Prophylactic Medical Countermeasure

    SBC: Flow Pharma, Inc.            Topic: CBD18A002

    Through this STTR contract, we propose to evaluate the efficacy of our vaccine, FlowVax Marburg, in nonhuman primates (NHPs). This will be achieved through four Tasks. In Task 1, we will manufacture the vaccine in a quantity sufficient for the animal studies. In Task 2, we will perform MHC genotyping on a representative population of NHPs and, based on results, select a set of MHC-matched NHPs for ...

    STTR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense
  10. Preclinical Development of OCF001 for Treatment of Yeast Infections

    SBC: Sano Chemicals, Inc.            Topic: NIAID

    Project Summary Occidiofungins (A-D) are cyclic nonribosomally synthesized antifungal peptides with submicromolar fungicidal activity against a broad spectrum of fungi. Optimization of the production and isolation of occidiofungins from liquid cultures has been performed. The production and isolation of predominantly one analog, called occidiofungin B (OCF001), supports its commercial development ...

    STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government